These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Risk factors for arteriosclerosis]. Henzen C Praxis (Bern 1994); 2001 Jan; 90(4):91-5. PubMed ID: 11213573 [TBL] [Abstract][Full Text] [Related]
5. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice. Antoniades C; Tousoulis D; Tentolouris C; Toutouzas P; Stefanadis C Herz; 2003 Nov; 28(7):628-38. PubMed ID: 14689123 [TBL] [Abstract][Full Text] [Related]
6. Role of oxidative modifications in atherosclerosis. Stocker R; Keaney JF Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655 [TBL] [Abstract][Full Text] [Related]
7. [New information on the pathophysiology of atherosclerosis]. Reiner Z; Tedeschi-Reiner E Lijec Vjesn; 2001; 123(1-2):26-31. PubMed ID: 11379194 [TBL] [Abstract][Full Text] [Related]
8. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis. Cox DA; Cohen ML Pharmacol Rev; 1996 Mar; 48(1):3-19. PubMed ID: 8685247 [TBL] [Abstract][Full Text] [Related]
9. [The role of LDL in the origin and progression of atherosclerosis: pathobiological concepts on the origin and development of atherosclerotic lesions and the role of the endothelium]. De Caterina R; Lenzi S G Ital Cardiol; 1998 Feb; 28(2):158-67. PubMed ID: 9534057 [TBL] [Abstract][Full Text] [Related]
10. Risk factors and their role in the diseases of the arterial wall. Patel ST; Kent KC Semin Vasc Surg; 1998 Sep; 11(3):156-68. PubMed ID: 9763116 [TBL] [Abstract][Full Text] [Related]
11. The pathophysiology of atherosclerosis. Mitchell ME; Sidawy AN Semin Vasc Surg; 1998 Sep; 11(3):134-41. PubMed ID: 9763113 [TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Cersosimo E; DeFronzo RA Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274 [TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [TBL] [Abstract][Full Text] [Related]
15. [Action of natural estrogens on the vessel wall: molecular mechanisms and clinical implications]. Lüscher TF; Barton M; Wight E; Espinosa E; Yang Z Schweiz Med Wochenschr; 1996 Oct; 126(41):1748-55. PubMed ID: 8966507 [TBL] [Abstract][Full Text] [Related]
16. Identifying the vulnerable patient with rupture-prone plaque. Weintraub HS Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869 [TBL] [Abstract][Full Text] [Related]
17. The enigma of the endothelium. Mathavan A; Shankar KJ; Misra KP J Assoc Physicians India; 1999 Oct; 47(10):998-1002. PubMed ID: 10778696 [TBL] [Abstract][Full Text] [Related]
18. A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease. Hovingh GK; Brownlie A; Bisoendial RJ; Dube MP; Levels JH; Petersen W; Dullaart RP; Stroes ES; Zwinderman AH; de Groot E; Hayden MR; Kuivenhoven JA; Kastelein JJ J Am Coll Cardiol; 2004 Oct; 44(7):1429-35. PubMed ID: 15464323 [TBL] [Abstract][Full Text] [Related]
19. Regression of atherosclerosis: which components regress and what influences their reversal. Kramsch DM; Blankenhorn DH Wien Klin Wochenschr; 1992; 104(1):2-9. PubMed ID: 1546480 [TBL] [Abstract][Full Text] [Related]
20. [Endothelial function in high risk cardiovascular patients]. Káli A; Jánosi A Orv Hetil; 2006 Jan; 147(3):99-106. PubMed ID: 16515028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]